eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

1/2019
vol. 11
 
Share:
Share:
more
 
 
abstract:
Original paper

A nomogram to determine required seed air kerma strength in planar Cesium-131 permanent seed implant brachytherapy

Emily Hubley, Michael Trager, Voichita Bar-Ad, Adam Luginbuhl, Laura Doyle

J Contemp Brachytherapy 2019; 11, 1: 91–98
Online publish date: 2019/02/05
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Purpose
Intraoperatively implanted Cesium-131 (131Cs) permanent seed brachytherapy is used to deliver highly localized re-irradiation in recurrent head and neck cancers. A single planar implant of uniform air kerma strength (AKS) seeds and 10 mm seed-to-seed spacing is used to deliver the prescribed dose to a point 5 mm or 10 mm perpendicular to the center of the implant plane. Nomogram tables to quickly determine the required AKS for rectangular and irregularly shaped implants were created and dosimetrically verified. By eliminating the need for a full treatment planning system plan, nomogram tables allow for fast dose calculation for intraoperative re-planning and for a second check method.

Material and methods
TG-43U1 recommended parameters were used to create a point-source model in MATLAB. The dose delivered to the prescription point from a single 1 U seed at each possible location in the implant plane was calculated. Implant tables were verified using an independent seed model in MIM Symphony LDR™. Implant tables were used to retrospectively determine seed AKS for previous cases: three rectangular and three irregular.

Results
For rectangular implants, the percent difference between required seed AKS calculated using MATLAB and MIM was at most 0.6%. For irregular implants, the percent difference between MATLAB and MIM calculations for individual seed locations was within 1.5% with outliers of less than 3.1% at two distal locations (10.6 cm and 8.8 cm), which have minimal dose contribution to the prescription point. The retrospectively determined AKS for patient implants using nomogram tables agreed with previous calculations within 5% for all six cases.

Conclusions
Nomogram tables were created to determine required AKS per seed for planar uniform AKS 131Cs implants. Comparison with the treatment planning system confirms dosimetric accuracy that is acceptable for use as a second check or for dose calculation in cases of intraoperative re-planning.

keywords:

brachytherapy, Cesium-131, intraoperative brachytherapy, permanent seed implant, head and neck cancer, nomogram

references:
Murphy MK, Piper RK, Greenwood LR et al. Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy. Med Phys 2004; 31: 1529-1538.
Yang R, Wang J, Zhang H. Dosimetric study of Cs-131, I-125, and Pd-103 seeds for permanent prostate brachytherapy. Cancer Biother Radiopharm 2009; 24: 701-705.
Armpilia CI, Dale RG, Coles IP et al. The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants. Int J Radiat Oncol Biol Phys 2003; 55: 378-385.
Bice WS, Prestidge BR, Kurtzman SM et al. Recommendations for permanent prostate brachytherapy with 131Cs: A consensus report from the Cesium Advisory Group. Brachytherapy 2008; 7: 290-296.
Kehwar TS. Use of Cesium-131 radioactive seeds in prostate permanent implants. J Med Phys 2009; 34: 191-193.
Yue N, Heron DE, Komanduri K et al. Prescription dose in permanent Cs131 seed prostate implants. Med Phys 2005; 32: 2496-2502.
Wernicke AG, Hirschfeld CB, Smith AW et al. Clinical outcomes of large brain metastases treated with neurosurgical resection and intraoperative Cesium-131 brachytherapy: results of a prospective trial. Int J Radiat Oncol 2017; 98: 1059-1068.
Luo W, Molloy JA, Aryal P et al. A First Report on GYN Permanent Seed Implant with CS-131. RSNA 2013 Scientific Assembly and Annual meeting, December 1-6, 2013, Chicago, IL. http://archive.rsna.org/2013/13042704.html
Wooten CE, Randall M, Edwards J et al. Implementation and early clinical results utilizing Cs-131 permanent interstitial implants for gynecologic malignancies. Gynecol Oncol 2014; 133: 268-273.
Parashar B, Port J, Arora S et al. Analysis of stereotactic radiation vs. wedge resection vs. wedge resection plus Cesium-131 brachytherapy in early stage lung cancer. Brachytherapy 2015; 14: 648-654.
Pham A, Arora S, Wernicke AG et al. Cesium-131 brachytherapy in high-risk and recurrent head and neck cancers: first report of long-term outcomes. J Contemp Brachytherapy 2015; 7: 445-452.
Parashar B, Wernicke AG, Pavese A et al. Cesium-131 permanent seed brachytherapy: Dosimetric evaluation and radiation exposure to surgeons, radiation oncologists, and staff. Brachytherapy 2011; 10: 508-513.
To DT, Harrison AS, Luginbuhl A et al. Single institution implementation of Cs-131 interstitial brachytherapy for previously irradiated patients with resectable recurrent head and neck carcinoma. Brachytherapy 2016; 15: S166.
Chen Z, Bongiorni P, Nath R. Dose rate constant of a Cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry. Med Phys 2005; 32: 3279-3285.
Chiu-Tsao ST, Napoli JJ, Davis SD et al. Dosimetry for 131Cs and 125I seeds in solid water phantom using radiochromic EBT film. Appl Radiat Isot 2014; 92: 102-114.
Henschke UK, Lawrence DC. Cesium-131 seeds for permanent implants. Radiology 1965; 85: 1117-1119.
Rivard MJ. Brachytherapy dosimetry parameters calculated for a Cs131 source. Med Phys 2007; 34: 754-762.
Wang J, Zhang H. Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation. Med Phys 2008; 35: 1571-1579.
Wittman RS, Fisher DR. Multiple-estimate monte carlo calculation of the dose rate constant for a Cesium-131 interstitial brachytherapy seed. Med Phys 2007; 34: 49-54.
Anderson LL. Spacing nomograph for interstitial implants of 125 I seeds. Med Phys 1976; 3: 48-51.
Anderson LL, Moni JV, Harrison LB. A nomograph for permanent implants of palladium-103 seeds. Int J Radiat Oncol Biol Phys 1993; 27: 129-135.
Henschke UK, Cevc P. Dimension averaging a simple method for dosimetry of interstitial implants. Radiobiol Radiother (Berl) 1968; 9: 287-298.
Rivard MJ, Coursey BM, DeWard et al. Update of the AAPM Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 2004; 31: 633-674.
Hardin MT, To DT, Yu Y et al. Commissioning of the MIM symphony low dose rate brachytherapy planning system for the treatment of head and neck cancers. Brachytherapy 2016; 15: S66-S67.
Quimby EH, Castro V. The calculation of dosage in interstitial radium therapy. Am J Roentgenol Radium Ther Nucl Med 1953; 70: 739-749.
Paterson R, Parker H. A dosage system for gamma ray therapy. Br J Radiol 1934; 7: 578-579.
 
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe